Research programme: anti-LRG1 antibody therapeutics - Antitope/University College Longon
Latest Information Update: 03 Sep 2014
At a glance
- Originator Antitope; University College London
- Class Antibodies
- Mechanism of Action Angiogenesis inhibitors; LRG1 protein inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Research Age-related macular degeneration
Most Recent Events
- 27 Aug 2014 Early research in Age-related macular degeneration in United Kingdom (Ophthalmic)